BRÈVE publiée le 30/04/2024 à 13:05, il y a 2 années 1 mois Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Clinical Trial Cell Therapy Emmecell Corneal Edema Non-surgical Treatment
BRÈVE publiée le 30/04/2024 à 13:05, il y a 2 années 1 mois Emmecell achève le dosage final de la thérapie cellulaire dans le cadre d'un essai clinique américain sur l'œdème cornéen Thérapie Cellulaire Essai Clinique Emmecell Œdème Cornéen Traitement Non Chirurgical
COMMUNIQUÉ DE PRESSE publié le 30/04/2024 à 13:00, il y a 2 années 1 mois Emmecell Completes Final Cell Therapy Dosing in U.S. Clinical Trial for Corneal Edema Emmecell completes final dose administration for the last patient in U.S. trial for EO2002, a non-surgical cell therapy for corneal edema, showing promise for treating vision loss Clinical Trial Cell Therapy Emmecell Corneal Edema EO2002
Publié le 27/06/2026 à 01:40, il y a 8 heures 10 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 9 heures 50 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 10 heures 50 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 11 heures Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 26/06/2026 à 22:15, il y a 11 heures 35 minutes Revive Therapeutics Announces Proposed Private Placement
Publié le 27/06/2026 à 00:05, il y a 9 heures 45 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 9 heures 46 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 10 heures 14 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 10 heures 14 minutes EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 10 heures 23 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
